HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Congenital disorder of glycosylation type Ik (CDG-Ik): a defect of mannosyltransferase I.

Abstract
This study describes the discovery of a new inherited disorder of glycosylation named "CDG-Ik." CDG-Ik (congenital disorder of glycoslyation type Ik) is based on a defect of human mannosyltransferase I (MT-I [MIM 605907]), an enzyme necessary for the elongation of dolichol-linked chitobiose during N-glycan biosynthesis. Mutations in semiconserved regions in the corresponding gene, HMT-1 (yeast homologue, Alg1), in two patients caused drastically reduced enzyme activity, leading to a severe disease with death in early infancy. One patient had a homozygous point mutation (c.773C-->T, S258L), whereas the other patient was compound heterozygous for the mutations c.773C-->T and c.1025A-->C (E342P). Glycosylation and growth of Alg1-deficient PRY56 yeast cells, showing a temperature-sensitive phenotype, could be restored by the human wild-type allele, whereas only slight restoration was observed after transformation with the patients' alleles.
AuthorsChristian Kranz, Jonas Denecke, Ludwig Lehle, Kristina Sohlbach, Stefanie Jeske, Friedhelm Meinhardt, Rainer Rossi, Sonja Gudowius, Thorsten Marquardt
JournalAmerican journal of human genetics (Am J Hum Genet) Vol. 74 Issue 3 Pg. 545-51 (Mar 2004) ISSN: 0002-9297 [Print] United States
PMID14973782 (Publication Type: Journal Article)
Chemical References
  • Polyisoprenyl Phosphate Monosaccharides
  • N-acetylglucosaminylpyrophosphoryldolichol
  • Mannosyltransferases
  • chitobiosyldiphosphodolichol beta-mannosyltransferase
Topics
  • Genetic Diseases, Inborn
  • Glycosylation
  • Humans
  • Mannosyltransferases (genetics, metabolism)
  • Polyisoprenyl Phosphate Monosaccharides (metabolism)
  • Saccharomyces (enzymology, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: